Tumorigenicity of Vero cells.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Biological Standardization

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-1157(84)80063-3PMID 6526826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human muscle: a model for the study of human neoplasia

  2004cited by this paper
• Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes

  1983cited by this paper
• Tumors; a mixed bag of cells.

  1982cited by this paper
• A comparison of three routes of inoculation for testing tumorigenicity of cell lines in nude mice.

  1981cited by this paper
• The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.

  1981cited by this paper
• Use of the ATG-treated newborn rat for in vivo tumorigenicity testing of cell substrates.

  1981cited by this paper
• Use of the ATG-treated newborn rat for in vivo tumorigenicity testing of cell substrates.

  1981cited by this paper
• Tumours of the Kidney, Renal Pelvis and Ureter

  1979cited by this paper
• Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.

  1977cited by this paper
• Colony morphology and growth in agarose as tests for spontaneous neoplastic transformation in vitro.

  1977cited by this paper

• History of Rabies and Rabies Vaccines

  2020cites this paper
• Suspension culture of Vero cells for the production of adenovirus type 5

  2020cites this paper
• Rabies and Rabies Vaccines

  2020cites this paper
• Human and animal vaccines

  2020cites this paper
• Novel endogenous simian retroviral integrations in Vero cells: implications for quality control of a human vaccine cell substrate

  2018cites this paper
• Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization

  2017influential citation
• Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

  2017cites this paper
• Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication

  2017cites this paper
• Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1

  2015cites this paper
• Development of novel inactivated poliovirus vaccines: Breaking away from convention

  2015cites this paper
• Structure and Potential Cellular Targets of HAMLET-like Anti-Cancer Compounds made from Milk Components.

  2015cites this paper
• Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells

  2014cites this paper
• MicroRNAs as potential biomarkers for VERO cell tumorigenicity.

  2014cites this paper
• Improved poliovirus d-antigen yields by application of different Vero cell cultivation methods

  2014cites this paper
• mproved poliovirus d-antigen yields by application of different Vero ell cultivation methods

  2014cites this paper
• The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line

  2014cites this paper
• Accelerated Biopharmaceutical Development: Vero Cell Technology and Pandemic Influenza Vaccine Production

  2013cites this paper
• Culture systems: embryo co-culture.

  2012cites this paper
• Cell Culture-Derived Influenza Vaccines

  2011cites this paper
• Chemical Induction of Endogenous Retrovirus Particles from the Vero Cell Line of African Green Monkeys

  2011cites this paper
• Developing cell culture-derived pandemic vaccines.

  2010cites this paper
• Patterns of microRNA Expression in Non-Human Primate Cells Correlate with Neoplastic Development In Vitro

  2010influential citation
• Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines

  2009cites this paper
• Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

  2009cites this paper
• Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.

  2008cites this paper
• Obtención y caracterización de una línea celular diploide de riñón humano

  2004cites this paper
• Mosquito and mammalian cells grown on microcarriers for four‐serotype dengue virus production: Variations in virus titer, plaque morphology, and replication rate

  2004cites this paper
• What Is Coming Through That Needle? The Problem of Pathogenic Vaccine Contamination

  2002cites this paper
• Stationary and Microcarrier Cell Culture Processes for Propagating Japanese Encephalitis Virus

  2002cites this paper
• Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

  1998cites this paper
• Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine.

  1997cites this paper
• The place of DTP/eIPV vaccine in routine pediatric vaccination

  1994cites this paper
• Preparation of human rabies vaccine in VERO cell culture using a microcarrier system.

  1993cites this paper
• Feasible improvements in vaccines in the Expanded Programme on Immunization.

  1989cites this paper
• Opportunities for Replacement, Reduction and Refinement: Human Viral Vaccines

  1988cites this paper
• Characterization of Vero cells.

  1988cites this paper
• Rabies vaccine production in animal cell cultures.

  1987cites this paper
• Heterotransplantation studies with tissue culture cell lines in various animal and in vitro host systems.

  1985cites this paper
• Tumorigenicity testing of primate cell lines in nude mice, muscle organ culture and for colony formation in soft agarose.

  1985cites this paper